That projection is far higher than the global market valued in 2010 at $16 billion. Markets for infection control devices and products were $8.3 billion in the year 2010 and are expected to reach $10.3 billion by 2011. This market is forecasted to cross $18.3 billion by 2016 at a CAGR of 12 percent.
Additionally, the global market for pharmaceutical treatments is expected to reach $6 billion by 2016 at a 5.8 percent CAGR. The U.S. holds nearly half of the global market for healthcare-association infection products.
Related Articles on Healthcare-Acquired Infections:
10 Proven Ways to Reduce Hospital Readmissions
Basic Infection Prevention Saved Children’s Hospitals $104M Over 5 Yrs
Readmissions in New York Cost $3.7B
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
